Seung Joon Lee

Seung Joon Lee

Auto-generated profile, based on publicly available information

Seung Joon Lee

Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Biomaterials
Verified
Journal Article
Closed access
AAAysegul Altunbas
Aysegul Altunbas
SLSeung J. Lee
Seung J. Lee
SRSigrid A. Rajasekaran
Sigrid A. Rajasekaran
JSJoel P. Schneider
Joel P. Schneider
DPDarrin Pochan
Darrin Pochan

18 April 2011 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SLSeung Joon Lee
Seung Joon Lee
CKCandice Krauthauser
Candice Krauthauser
VMVictoria Maduskuie
Victoria Maduskuie
PFPaul T Fawcett
Paul T Fawcett
JOJames M Olson
James M Olson
SRSigrid A Rajasekaran
Sigrid A Rajasekaran
Background: Medulloblastoma is the most common brain tumor in children, and its prognosis is worse than for many other common pediatric cancers. Survivors undergoing treatment suffer from serious therapy-related side effects. Thus, it is imperative to identify safer, effective treatments for medulloblastoma. In this study we evaluated the anti-cancer potential of curcumin in medulloblastoma by testing its ability to induce apoptosis and inhibit tumor growthin vitroandin vivousing established medulloblastoma models.Methods: Using cultured medulloblastoma cells, tumor xenografts, and the Smo/Smo transgenic medulloblastoma mouse model, the antitumor effects of curcumin were testedin vitroandin vivo.Results: Curcumin induced apoptosis and cell cycle arrest at the G2/M phase in medulloblastoma cells. These effects were accompanied by reduced histone deacetylase (HDAC) 4 expression and activity and increased tubulin acetylation, ultimately leading to mitotic catastrophe. Inin vivomedulloblastoma xenografts, curcumin reduced tumor growth and significantly increased survival in the Smo/Smo transgenic medulloblastoma mouse model.Conclusions: Thein vitroandin vivodata suggest that curcumin has the potential to be developed as a therapeutic agent for medulloblastoma.

23 March 2016 in eLife
Verified
Journal Article
Open access
YMYevgeniya A Mironova
Yevgeniya A Mironova
GLGuy M Lenk
Guy M Lenk
JLJing-Ping Lin
Jing-Ping Lin
SLSeung Joon Lee
Seung Joon Lee
JTJeffery L Twiss
Jeffery L Twiss
RGRoman J Giger
Roman J Giger
Proper development of the CNS axon-glia unit requires bi-directional communication between axons and oligodendrocytes (OLs). We show that the signaling lipid phosphatidylinositol-3,5-bisphosphate [PI(3,5)P2] is required in neurons and in OLs for normal CNS myelination. In mice, mutations of Fig4, Pikfyve or Vac14, encoding key components of the PI(3,5)P2 biosynthetic complex, each lead to impaired OL maturation, severe CNS hypomyelination and delayed propagation of compound action potentials. Primary OLs deficient in Fig4 accumulate large LAMP1+ and Rab7+ vesicular structures and exhibit reduced membrane sheet expansion. PI(3,5)P2 deficiency leads to accumulation of myelin-associated glycoprotein (MAG) in LAMP1+perinuclear vesicles that fail to migrate to the nascent myelin sheet. Live-cell imaging of OLs after genetic or pharmacological inhibition of PI(3,5)P2 synthesis revealed impaired trafficking of plasma membrane-derived MAG through the endolysosomal system in primary cells and brain tissue. Collectively, our studies identify PI(3,5)P2 as a key regulator of myelin membrane trafficking and myelinogenesis.

15 July 2015 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
AKAshley L. Kalinski
Ashley L. Kalinski
RSRahul Sachdeva
Rahul Sachdeva
CGCynthia Gomes
Cynthia Gomes
SLSeung Joon Lee
Seung Joon Lee
ZSZalak Shah
Zalak Shah
JTJeffery Lewis Twiss
Jeffery Lewis Twiss
Although intra-axonal protein synthesis is well recognized in cultured neurons and during development in vivo, there have been few reports of mRNA localization and/or intra-axonal translation in mature CNS axons. Indeed, previous work indicated that mature CNS axons contain much lower quantities of translational machinery than PNS axons, leading to the conclusion that the capacity for intra-axonal protein synthesis is linked to the intrinsic capacity of a neuron for regeneration, with mature CNS neurons showing much less growth after injury than PNS neurons. However, when regeneration by CNS axons is facilitated, it is not known whether the intra-axonal content of translational machinery changes or whether mRNAs localize into these axons. Here, we have used a peripheral nerve segment grafted into the transected spinal cord of adult rats as a supportive environment for regeneration by ascending spinal axons. By quantitative fluorescent in situ hybridization combined with immunofluorescence to unambiguously distinguish intra-axonal mRNAs, we show that regenerating spinal cord axons contain β-actin, GAP-43, Neuritin, Reg3a, Hamp, and Importin β1 mRNAs. These axons also contain 5S rRNA, phosphorylated S6 ribosomal protein, eIF2α translation factor, and 4EBP1 translation factor inhibitory protein. Different levels of these mRNAs in CNS axons from regenerating PNS axons may relate to differences in the growth capacity of these neurons, although the presence of mRNA transport and likely local translation in both CNS and PNS neurons suggests an active role in the regenerative process. SIGNIFICANCE STATEMENT Although peripheral nerve axons retain the capacity to locally synthesize proteins into adulthood, previous studies have argued that mature brain and spinal cord axons cannot synthesize proteins. Protein synthesis in peripheral nerve axons is increased during regeneration, and intra-axonally synthesized proteins have been shown to contribute to nerve regeneration. Here, we show that mRNAs and translational machinery are transported into axons regenerating from the spinal cord into the permissive environment of a peripheral nerve graft. Our data raise the possibility that spinal cord axons may make use of localized protein synthesis for regeneration.

15 April 2013 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
SYSoonmoon Yoo
Soonmoon Yoo
HKHee Jeong Kim
Hee Jeong Kim
PKPaul Kim
Paul Kim
CDChristopher Donnelly
Christopher Donnelly
AKAshley L. Kalinski
Ashley L. Kalinski
JTJeffery Lewis Twiss
Jeffery Lewis Twiss
Localized translation of axonal mRNAs contributes to developmental and regenerative axon growth. Although untranslated regions (UTRs) of many different axonal mRNAs appear to drive their localization, there has been no consensus RNA structure responsible for this localization. We recently showed that limited expression of ZBP1 protein restricts axonal localization of both β‐actin and GAP‐43 mRNAs. β‐actin 3′UTR has a defined element for interaction with ZBP1, but GAP‐43 mRNA shows no homology to this RNA sequence. Here, we show that an AU‐rich regulatory element (ARE) in GAP‐43′s 3′UTR is necessary and sufficient for its axonal localization. Axonal GAP‐43 mRNA levels increase after in vivo injury, and GAP‐43 mRNA shows an increased half‐life in regenerating axons. GAP‐43 mRNA interacts with both HuD and ZBP1, and HuD and ZBP1 co‐immunoprecipitate in an RNA‐dependent fashion. Reporter mRNA with the GAP‐43 ARE competes with endogenous β‐actin mRNA for axonal localization and decreases axon length and branching similar to the β‐actin 3′UTR competing with endogenous GAP‐43 mRNA. Conversely, over‐expressing GAP‐43 coding sequence with its 3′UTR ARE increases axonal elongation and this effect is lost when just the ARE is deleted from GAP‐43′s 3′UTR. image We have recently found that over‐expression of GAP‐43 using an axonally targeted construct with the 3′UTRs of GAP‐43 promoted elongating growth of axons, while restricting the mRNA to the cell body with the 3′UTR of γ‐actin had minimal effect on axon length. In this study, we show that the ARE in GAP‐43′s 3′UTR is responsible for localization of GAP‐43 mRNA into axons and is sufficient for GAP‐43 protein's role in elongating axonal growth.

24 February 2016 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
JSJessie E. P. Sun
Jessie E. P. Sun
BSBrandon Stewart
Brandon Stewart
ALAlisa Litan
Alisa Litan
SLSeung Joon Lee
Seung Joon Lee
JSJoel P. Schneider
Joel P. Schneider
DPDarrin Pochan
Darrin Pochan
MAX8 β-hairpin peptide hydrogel is a solid, preformed gel that can be syringe injected due to shear-thinning properties and can recover solid gel properties immediately after injection. This behavior makes the hydrogel an excellent candidate as a local drug delivery vehicle. In this study, vincristine, a hydrophobic and commonly used chemotherapeutic, is encapsulated within MAX8 hydrogel and shown to release constantly over the course of one month. Vincristine was observed to be cytotoxic in vitro at picomolar to nanomolar concentrations. The amounts of drug released from the hydrogels over the entire time-course were in this concentration range. After encapsulation, release of vincristine from the hydrogel was observed for four weeks. Further characterization showed the vincristine released during the 28 days remained biologically active, well beyond its half-life in bulk aqueous solution. This study shows that vincristine-loaded MAX8 hydrogels are excellent candidates as drug delivery vehicles, through sustained, low, local and effective release of vincristine to a specific target. Oscillatory rheology was employed to show that the shear-thinning and re-healing, injectable-solid properties that make MAX8 a desirable drug delivery vehicle are unaffected by vincristine encapsulation. Rheology measurements also were used to monitor hydrogel nanostructure before and after drug encapsulation.